Contact
Please use this form to send email to PR contact of this press release:
MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
TO:
Please use this form to send email to PR contact of this press release:
MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
TO: